Viewing Study NCT03606967


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-01-24 @ 11:43 PM
Study NCT ID: NCT03606967
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2018-07-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Invasive Breast Carcinoma View
None Metastatic Triple-Negative Breast Carcinoma View
Keywords: